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Neonatal outcome of pregnancies complicated by hypertensive
disorders between 34 and 37 weeks of gestation: a 7
year retrospective analysis of a national registry
Josje Langenveld, MD; Anita C. J. Ravelli, PhD; Anton H. van Kaam, MD, PhD; David P. van der Ham, MD;
Maria G. van Pampus, MD, PhD; Martina Porath, MD, PhD; Ben Willem Mol, MD, PhD; Wessel Ganzevoort, MD, PhDOBJECTIVE: The objective of the study was to determine the neonatal
morbidity in late preterm infants born from mothers with a hypertensive
disorder.
STUDY DESIGN: Data were obtained from the national Perinatal Regis-
try in The Netherlands on women who delivered between 340 and
66 weeks with gestational hypertension (n  4316), preeclampsia
(n 1864), and normotensive controls (n 20,749).
RESULTS: Children from mothers with preeclampsia had an increased
risk for admission to the neonatal intensive care unit compared with
children from normotensive mothers (odds ratio [OR], 2.0; 95% confi-
dence interval [CI], 1.8–2.2). A cesarean delivery and decreasing ges-
weeks of gestation: a 7 year retrospective analysis of a national registry. Am J Obst
t
w
002-9378/$36.00 • © 2011 Mosby, Inc. All rights reserved. • doi: 10.1016
540.e1 American Journal of Obstetrics& Gynecology DECEMBER 2011tational age were independent risk factors for neonatal respiratory mor-
bidity. Gestational hypertension or preeclampsia reduced the risk of
respiratory distress syndrome compared with the control group (OR,
0.81; 95% CI, 0.64–1.0 and OR, 0.69; 95% CI, 0.49–0.96,
respectively).
CONCLUSION: Neonatal morbidity in the late preterm period is consid-
erable. Hypertensive disorders appear to protect for neonatal respira-
torymorbidity, but higher rates of cesarean section diminish this protec-
tive effect.
Key words: newborn, preeclampsia, preterm, respiratory distress
syndromeCite this article as: Langenveld J, Ravelli ACJ, van Kaam AH, et al. Neonatal outcome of pregnancies complicated by hypertensive disorders between 34 and 37
et Gynecol 2011;205:540.e1-7.
fThe majority of hypertensive disor-ders of pregnancy (gestational hy-
pertension [GH], preeclampsia [PE])
present at term or late preterm, only 10%
occur before 32 weeks.1 Hypertension in
pregnancy is associated with severe com-
plications such as eclampsia, placental
abruption, HELLP (hemolysis, elevated
liver enzymes, and low platelet count)
syndrome, preterm delivery, or even fe-
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of adverse perinatal outcome increases
with lower gestational age.4,5
The only causal treatment for hyper-
tensive disorders of pregnancy is to de-
liver the baby. There is a general consen-
sus that in pregnancies complicated by
early preeclampsia (eg, 32 weeks’ ges-
ational age), temporizing management
ith close monitoring of the mother and
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/j.ajog.2011.07.003fetus is justified, and prolongation of
pregnancy can be achieved without irre-
versible maternal morbidity and with
improved neonatal outcome.6,7 In con-
trast, in women with mild GH or PE at
term, induction of labor resulted in a de-
crease of progression to severe disease or
complications as well as a decreased
number of cesarean sections compared
with temporizing management.8 More-
over, induction of labor showed a trend
to a better neonatal outcome.
Until now, only a few studies have fo-
cused on the management of women
with hypertensive disorders between
340 and 366 weeks of gestational age.
The National Institute for Health and
Clinical Excellence (NICE) guideline for
hypertensive disorders during preg-
nancy refers in the 2010 consensus state-
ment to the issue of mild or moderate
preeclampsia between 34 and 36 weeks
of gestation in terms of a gray zone at
which the optimal timing of birth is not
clear.9 Babies born late preterm (eg, 340
to 366 weeks’ gestational age) account















































www.AJOG.org Obstetrics Researchthat these late preterm children have sig-
nificantly more morbidity than babies
born at term.11-17 However, it is un-
known whether this finding also applies
to infants born from mothers with a hy-
pertensive disorder because in most
studies these women were excluded from
analysis. This also makes it difficult to
determine the optimal obstetric man-
agement for these patients.
To improve our understanding on the
neonatal outcome of this specific popu-
lation and its causative factors, we ana-
lyzed the data on neonatal morbidity in
infants born from mothers with a hyper-
tensive disorder between 34 and 37
weeks’ gestation from the Dutch Na-
tional Registry, compared with morbid-
ity rates of children born between 34 and




Data were obtained from the Nether-
lands Perinatal Registry (PRN registry)
between January 2000 and December
2006.18 Since 2000 all gestation/delivery
ecords (National Delivery Record
LVR]), both home deliveries (LVR-1
egistry) and hospital deliveries (LVR-2
egistry), are combined with neonatal
dmission records (National Neonatal
egister [LNR]) into a national perinatal
egister (PRN). Méray et al19 and Tromp
et al20 have extensively described the
echnical approach and subsequent vali-
ation of the probabilistic linkage of
hese 3 anonymous population-based
egistries of the midwives, obstetricians,
nd neonatalogists.
The LVR-1 and LVR-2 register have a
6% national coverage on all births (ap-
roximately 180,000 deliveries per year
t more than 16 completed weeks of ges-
ation in The Netherlands). The LNR
egistry has a 68% coverage of all hospi-
als in The Netherlands of whom the 10
erinatal centers have a coverage of
00% and the other hospitals have 58%.
For the present study, we included all
omen who delivered between 340 and
66 weeks of gestation. Exclusion crite-
ria were chronic hypertension, multiple
pregnancies, noncephalic presentation,congenital malformations, mothers di-
agnosed with AIDS, diabetes, or drug use
(drugs, not cannabis), and more than 24
hours of rupture of membranes (in The
Netherlands an expectant monitoring
management is often followed for this
latter group in the late preterm period).
These exclusion criteria were selected
because these specific conditions them-
selves are related to neonatal morbidi-
ties. If neonatal follow-up was not avail-
able, data were excluded. From the
available data, subjects whom the moth-
ers were diagnosed with gestational hy-
pertension (GH group) or preeclampsia
(PE group) were selected in. The other
patients were the normotensive control
group (preterm delivery without a
reason).
GH was defined as de novo hyperten-
sion, occurring after 20 weeks’ gesta-
tional age. Hypertension is defined as a
diastolic blood pressure of 90 mm Hg or
greater or a systolic blood pressure of 140
mm Hg or greater. PE was defined as de
novo hypertension after 20 gestational
weeks and proteinuria (300 mg/day or
a spot urine protein/creatinine ratio of
30 mg/mmol).21 Patients could be in-
cluded based only on their diastolic
blood pressure and on the amount of
proteinuria. The systolic blood pressure
is not an item in this national database.
This means that we might have missed a
small group of patients that did not reach
a diastolic blood pressure of 90 mmHg or
greater during their entire pregnancy.
According to the national guidelines,
calculation of gestational age was based
on the first day of the last menstrual pe-
riod and verified by a routinely per-
formed first-trimester ultrasound in all
patients.22
Maternal baseline characteristics re-
corded were maternal age, ethnicity, and
parity. Variables recorded were gesta-
tional age at delivery, birthweight, small
for gestational age (SGA; defined as
birthweight below the 10th percentile
adjusted for gestational age based on a
local reference population), and a 5 min-
ute Apgar score less than 7.0.
Poor neonatal outcome included ad-
mission to the neonatal intensive care
unit (NICU), metabolic and gastrointes-
tinal morbidity subdivided in hypogly- c
DECEMBER 2011 Americcemia (defined as glucose serum or
plasma level2.5 mmol/L), hyperbiliru-
inemia (indirect hyperbilirubinemia
efined as above the phototherapy level,
irect hyperbilirubinemia defined as
10% of the total serum bilirubine), or
ny stage of necrotizing enterocolitis
NEC).23
Respiratory problems were subdi-
vided in the need for oxygen therapy
more than 24 hours, any grade of infant
respiratory distress syndrome (RDS;
based on radiographic thorax findings
according to Giedeon grade I-IV), bron-
chopulmonary disease (BPD; defined as
more than 28 days of oxygen therapy or
oxygen therapy after 36 postmenstrual
weeks), transient tachypnoe of the new-
born (TTN; based on the typical clinical
picture [respiratory support that is rap-
idly weaned within the first 24 hours of
life]), and chest radiograph (high lung
volume).24
Neurologic morbidity was subdivided
into intracranial hemorrhage including
intraventricular hemorrhage (defined
according to Papile [grade I: hemorrhage
subependymal– germinal matrix; grade
II: intraventricular hemorrhage with
normal ventricle size; grade III: intraven-
tricular hemorrhage with ventricular di-
lation; and grade IV: parenchymal hem-
orrhage]); cerebral ischemia subdivided
in any grade of periventricular leucoma-
lacia (PVL; based on ultrasound images
or magnetic resonance imaging) or isch-
emia other than PVL any stage of hy-
poxic ischemic encephalopathy (HIE);
or convulsions.25,26 For this study only
he first admission data after birth were
sed.
Analysis
The study population was categorized in
3 groups: GH, PE, and the normotensive
control group. In later analysis, the 3
study groups were further subdivided by
3 groups of gestational age (GA) per
week: delivered at 340 to 346 GA; 350
to 356 and 360 to 366 GA.
Data are presented as n (percentage)
and in mean (SD), as appropriate. We
used2 to test for categoric data and Stu-
ent t test or 1-way analysis of variance
in case of more than 2 variables) for
ontinuous variables. Two-sided proba-


























































Research Obstetrics www.AJOG.orgbility of less than .05 was considered sta-
tistically significant. Data are expressed
in odds ratio (ORs) and 95% confidence
intervals (CIs).
A multivariable logistic regression
analysis was performed to examine re-
spiratory morbidity outcomes across
maternal subgroups (GH, PE, and con-
trol) controlling for gestational age in 3
weeks groups (34, 35, and 36 weeks) and
for onset or mode of delivery (in 7
groups). We checked for 2 possible inter-
action effects; first, we tested for interac-
tion between the study group (GH, PE,
and control) and gestational age in weeks
and second, between the study group and
mode of delivery.
Reference groups were the groups
with the lowest risk. In addition, we ad-
justed in the multivariable analysis for
parity, maternal ethnicity, and SGA.
Data of the multivariable analysis are ex-
pressed in ORs with 95% CIs. All analy-
ses were performed using SAS software
(version 9.2; SAS Institute, Cary, NC).
RESULTS
From January 1, 2000, until December
31, 2006, a total of 1,246,440 singleton
pregnancies were identified in the PRN
database. After application of our inclu-
sion and exclusion criteria, 26,929 deliv-
eries were the study population: 4316
women in the GH group (16%); 1864 in
the PE group (7%); and 20,749 in the
control group (77%).
Differences in onset of labor between
groups are shown in Table 1. Both induc-
TABLE 1
Onset of labor between 340 and 3
age in normotensive control mothe
Onset of labor Control
Gestational age, wks 34 0-6 35 0-6 36 0-6




2776 (86) 5051 (89) 10,458
...................................................................................................................




322 (9.9) 396 (7.0) 667
...................................................................................................................
Data are presented as n (percentage) of deliveries. Spontaneou
use of prostaglandins and/or oxytocin and/or artificial rupture
GH, gestational hypertension; PE, preeclampsia.
Langenveld. Neonatal morbidity in the late preterm periotion of labor and primary cesarean sec- f
540.e3 American Journal of Obstetrics& Gynecolotion occurred more frequently in the PE
group compared with the GH group,
with ORs of 2.8 (95% CI, 2.5–3.2) and
2.1 (95% CI, 1.9 –2.4), respectively.
Compared with the control group, the
risk of induction of labor and primary
cesarean section was increased even
more strongly (OR, 16; 95% CI, 15–18
and OR, 7.4; 95% CI, 6.6 – 8.2).
Baseline maternal and neonatal char-
acteristics of all groups are outlined in
Table 2. All data were significantly differ-
ent among the 3 groups. Birthweight was
significantly different between groups:
2686  425, 2482  510, and 2248 
61 g in the control, GH, and PE moth-
rs, respectively (P .001). SGA was sig-
ificantly more diagnosed in the PE
roup (27%) than in the GH group
18%; OR, 1.7; 95% CI, 1.5–1.9) and the
ontrol group (5.3%; OR, 6.7; 95% CI,
.9 –7.5). More children in the PE group
ere admitted to the NICU compared
ith the GH and control groups: OR, 1.6
95% CI, 1.4 –1.9) and relative risk 2.0
95% CI, 1.8 –2.2), respectively.
Table 3 presents the neonatal outcome
or each gestational age group in the nor-
otensive control, GH, and PE groups.
The incidences of hypoglycemia, hy-
erbilirubinemia, and NEC were not sig-
ificantly different between the PE and
H groups. However, there was a small
ut significant difference between the PE
nd control groups for hypoglycemia
OR, 1.5; 95% CI, 1.3–1.7) and for NEC
OR, 5.0; 95% CI, 2.1–11). Throughout
he groups there was a gestational age ef-
6 weeks of gestational
GH, and PE mothers
GH
Total 34 0-6 35 0-6 36 0-6 Total
20,749 (100) 741 (17) 1243 (29) 2332 (54) 4316 (1
.........................................................................................................................
18,285 (88) 352 (48) 705 (57) 1362 (58) 2419 (5
.........................................................................................................................
1079 (5.2) 117 (16) 260 (21) 660 (28) 1037 (2
.........................................................................................................................
1385 (6.7) 272 (37) 278 (22) 310 (13) 860 (2
.........................................................................................................................
rt of labor includes spontaneous start of contractions and/or spon
embranes.
mpregnancies complicated by a hypertensive disorder. Am Ject for hyperbilirubinemia and NEC n
gy DECEMBER 2011decreases with advancing gestational
ge) but not for hypoglycemia.
The incidence of 24 or more hours ox-
gen therapy was significantly different
etween the groups with an OR of 1.9
95% CI, 1.6 –2.2), between the PE and
he control group and an OR of 1.6 (95%
I, 1.3–1.9), and between the PE and the
H groups. The incidence of RDS was
ot significantly different between the 3
roups. The PE group more often expe-
ienced TTN compared with the control
OR, 1.5; 95% CI, 1.2–1.9) and with the
H group (OR, 1.5; 95% CI, 1.1–1.9).
he incidence of BPD was very low in all
groups. The risk for respiratory mor-
idity was inversely related to the gesta-
ional age.
The overall incidence of neurologic
orbidity was low. The incidences of
IE, cerebral ischemia (not PVL), PVL,
nd convulsions were not significantly
ifferent between all groups. In the PE
roup, there was an increased risk for in-
racranial hemorrhage compared with
he control group (OR, 2.2; 95% CI, 1.0 –
.8). Compared with the GH group, in-
idences were not significantly different.
he gestational effect was also present in
he neurologic morbidity (decreasing
ith advancing gestational age).
For the multivariable logistic regres-
ion analysis, interaction between all
ndependent variables were checked.
here were no interaction effects be-
ween groups. The incidences of the neu-
ologic and metabolic/gastrointestinal
orbidities were very low and therefore
PE
P value34 0-6 35 0-6 36 0-6 Total
430 (23) 560 (30) 874 (47) 1864 (100)
..................................................................................................................
55 (13) 80 (14) 202 (23) 337 (18)  .0001
..................................................................................................................
135 (31) 262 (47) 486 (56) 883 (47)  .0001
..................................................................................................................
240 (56) 218 (39) 186 (21) 644 (35)  .0001
..................................................................................................................
















































www.AJOG.org Obstetrics Researchsis showed an increased risk on respira-
tory morbidity with decreasing gesta-
tional age (Table 4). With the control
group as a reference, the odds on a respi-
ratory morbidity decreased in case of any
hypertensive disorder. The adjusted ORs
for RDS were 0.81 (95% CI, 0.64 –1.0)
and 0.69 (95% CI, 0.49 – 0.96) in the GH
and PE group, respectively.
For TTN the ORs were 0.81 (95% CI,
0.67– 0.98) and 0.91 (95% CI, 0.70 –1.2)
in the GH and PE groups, respectively.
The adjusted ORs for 24 or more hours
of oxygen therapy were 0.87 (95% CI,
0.76 – 0.99) and 1.0 (95% CI, 0.84 –1.2)
in the GH and PE groups, respectively.
Cesarean delivery was consistently asso-
ciated with higher odds on a respiratory
morbidity.
COMMENT
In this large retrospective analysis, we
analyzed the morbidity on late preterm
neonates born between 340 and 366
weeks of gestation because of a hyperten-
sive disorder of the mother, compared
with normotensive controls. Children
from mothers with PE or GH are more
often SGA, experience more morbidity
TABLE 2
Maternal and neonatal baseline ch





















5 minute Apgar score 7a 7
..........................................................................................................
NICU admission 24 ha 26
...................................................................................................................
SGA was defined as birthweight below the 10th percentile ad
GH, gestational hypertension; PE, preeclampsia; SGA, small s
a Data are presented as n (percentage) of deliveries; b Date ar
Langenveld. Neonatal morbidity in the late preterm perioand have higher NICU admission rates acompared with the neonates born from
normotensive mothers. The incidences
of gastrointestinal and neurologic mor-
bidity were very low (below 1%) for all
3 groups at all gestational ages.
Neonatal morbidity increased signifi-
cantly within all 3 groups when gesta-
tional age was decreasing. As gestational
age was approaching the term period, re-
spiratory morbidity decreased signifi-
cantly (below 1%). The multivariable
analysis confirmed lower gestational age
as an independent risk factor for respira-
tory morbidity. This result is in concor-
dance with the recent publication of
Hutcheon et al27 reporting on neonatal
morbidity between 36 and 41 weeks of
gestational age in women with gesta-
tional hypertension.
From literature we know that the inci-
dence on neonatal respiratory morbidity
is increased if mode of delivery is by ce-
sarean delivery compared with a vaginal
delivery.28-30Also in our study the multi-
ariable analysis indicates a primary ce-
arean delivery as an independent risk
actor for respiratory morbidity. Conse-
uently, the most logical explanation for
he lower odds on respiratory morbidity
n the multivariable analysis for the GH
cteristics of the cohort
GH, and PE mothers
l GH PE
(77) 4316 (16) 1864 (6
.........................................................................................................................
.8 (0.78) 35.7 (0.79) 35.5
.........................................................................................................................
.........................................................................................................................
.8 (5.0) 30.6 (4.8) 29.9
.........................................................................................................................
(84) 3874 (90) 1503 (8
.........................................................................................................................
(56) 2853 (66) 1303 (7
.........................................................................................................................
.........................................................................................................................
(425) 2482 (510) 2248 (4
.........................................................................................................................
(5.3) 776 (18) 508 (2
.........................................................................................................................
(3.5) 197 (4.6) 82 (4
.........................................................................................................................
(13) 684 (16) 419 (2
.........................................................................................................................
for gestational age based on a local reference population.
r gestational age.
sented as mean SD.
mpregnancies complicated by a hypertensive disorder. Am Jnd PE groups (compared with the non- n
DECEMBER 2011 Americignificant different incidences between
he 3 groups in Table 3) is the correction
or mode of delivery in the multivariable
nalysis (thus correcting for an indepen-
ent factor that increases the risk on re-
piratory morbidity). The rate of pri-
ary cesarean section was much higher
n the GH and PE groups, compared with
he control group. This is a potential
ource of bias because cesarean section
s probably associated with clinical
everity of the hypertensive disorders of
regnancy.
The strength of this study is the size of
he cohort, including patients over a long
ut recent period (2000 until 2006). Data
re derived from a reliable and validated
opulation-based data system. It in-
ludes almost all deliveries in the country
nd is therefore a good reflection of cur-
ent clinical decision making.
Our study also has some limitations.
irst, the reliability of our data depends
n the preciseness of registration of ob-
tetricians and pediatrics. The size of the
atabase minimizes this influence. Sec-
nd, missing neonatal follow-up in the
RN excluded almost 30% of the cohort.
e assume that the incidence of the neo-







) 29.9 (5.0)  .0001
..................................................................................................................
22,807 (85)  .0001
..................................................................................................................
15,846 (59)  .0001
..................................................................................................................
..................................................................................................................
2623 (460)  .0001
..................................................................................................................































e preot differ from those who do have a reg-



























Research Obstetrics www.AJOG.orgistered neonatal follow-up. Both type of
hospitals are equally distributed over the
country, use the same national guide-
lines, and are financed similarly. Some
data of interest were not available (sys-
tolic blood pressure and the administra-
tion of corticosteroids).
The lack of the systolic blood pressure
may have resulted in missing a small
group of patients that did not reach a di-
astolic blood pressure of 90 mm Hg or
greater after 20 weeks’ gestational age.
These patients might have been included
in the control group. Because this is
a small group of patients we do not be-
lieve this will significantly influence
the results.
The lack of information on adminis-
tered corticosteroids is another omission
in the data set. Standard care in The
Netherlands is not to give corticosteroids
after 34 weeks of gestation, so the num-
ber of patients who received corticoste-
TABLE 3
Neonatal outcome of normotensive
Neonatal outcome Control
Gestational age, wks 340-6 350-6 360-






Hypoglycemia 240 (7.4) 504 (8.9) 917
..........................................................................................................
Hyperbilirubinemia 940 (29) 1209 (21) 967
..........................................................................................................






527 (16) 469 (8.2) 410
..........................................................................................................
RDS 248 (7.7) 141 (2.5) 85
..........................................................................................................
BPD 1 (0.03) 0 (0.00) 0
..........................................................................................................






19 (0.59) 12 (0.21) 9
..........................................................................................................




9 (0.28) 5 (0.09) 7
..........................................................................................................
PVL 12 (0.37) 9 (0.16) 2
..........................................................................................................
Convulsions 13 (0.40) 14 (0.25) 16
...................................................................................................................
Data are presented as n (percentage).
BPD, bronchopulmonary disease; GH, gestational hypertensio
respiratory distress syndrome; TTN, transient tachypnea of th
Langenveld. Neonatal morbidity in the late preterm perioroids (before 34 weeks) is probably a very b
540.e5 American Journal of Obstetrics& Gynecolosmall group. It might be speculated that
patients who are admitted to the hospital
before 34 weeks but who delivered after
34 weeks did get corticosteroids. Fur-
thermore, the protective effect of hyper-
tensive disorders on respiratory morbid-
ity was present through all gestational
ages.
In what perspective should we see this
potential protective mechanism of a hy-
pertensive disorder on neonatal respira-
tory morbidity? Conflicting results on
the true effect of hypertensive disorders
on neonatal respiratory morbidity are
reported.31-33 Studies that did not cor-
ect for mode of delivery in their analysis
eport a higher risk on a neonatal res-
iratory disorder when hypertensive dis-
rders are present.32 However, the stud-
ies that corrected for mode of delivery
did not show a higher risk on neonatal
respiratory disorders or even a protective
effect. 31,33 This latter result is supported
ontrol), GH, and PE mothers between
GH
Total 340-6 350-6 360-6 T
) 2,0749 (100) 741 (17) 1243 (29) 2332 (54) 4
.........................................................................................................................
.........................................................................................................................
) 1661 (8.0) 84 (11) 128 (10) 238 (10)
.........................................................................................................................
) 3116 (15) 181 (24) 255 (21) 208 (8.9)
.........................................................................................................................
4) 18 (0.09) 3 (0.40) 3 (0.24) 3 (0.13)
.........................................................................................................................
.........................................................................................................................
) 1406 (6.8) 129 (17) 118 (9.5) 90 (3.9)
.........................................................................................................................
2) 474 (2.3) 50 (6.8) 33 (2.7) 18 (0.8)
.........................................................................................................................
0) 1 (0.00) 0 (0.00) 0 (0.00) 0 (0.00)
.........................................................................................................................
) 706 (3.4) 39 (5.3) 56 (4.5) 53 (2.3)
.........................................................................................................................
.........................................................................................................................
8) 40 (0.19) 8 (1.1) 2 (0.16) 4 (0.17)
.........................................................................................................................
7) 50 (0.24) 9 (1.2) 3 (0.24) 4 (0.17)
.........................................................................................................................
6) 21 (0.10) 5 (0.67) 1 (0.08) 3 (0.13)
.........................................................................................................................
2) 23 (0.11) 5 (0.67) 2 (0.16) 1 (0.04)
.........................................................................................................................
4) 43 (0.21) 6 (0.81) 10 (0.80) 10 (0.43)
.........................................................................................................................
E, hypoxic ischemic encephalopathy; NEC, necrotizing enterocoli
born.
mpregnancies complicated by a hypertensive disorder. Am Jy our study. t
gy DECEMBER 2011Because mode of delivery seems to be
n important influencing factor on the
utcome, one could speculate that in
ase of a hypertensive disorder of the
other in the late preterm period, in-
uction of labor is preferable before de-
erioration of the maternal condition oc-
urs and a primary cesarean section is the
nly solution for fast improvement of
he maternal condition. Choosing the
ight moment for delivery, though, re-
ains a difficult task for the obstetrician.
ith increasing gestational age, neona-
al morbidity will decrease but with in-
reasing risk for maternal deterioration.
n this perspective, the superior strategy
s a randomized controlled trial compar-
ng induction of labor with temporizing
anagement. A lesser alternative could
e a prospective closed cohort study.
In conclusion, neonatal morbidity in
abies born from mothers with hyper-
ensive disorders is still considerable in
0 and 366 weeks of gestation
PE
340-6 350-6 360-6 Total
(100) 430 (23) 560 (30) 874 (47) 1864 (100)
..................................................................................................................
..................................................................................................................
(10) 36 (8.4) 60 (11) 118 (14) 214 (11)
..................................................................................................................
(15) 93 (22) 83 (15) 104 (12) 280 (15)
..................................................................................................................
(0.21) 5 (1.2) 2 (0.36) 1 (0.11) 8 (0.43)
..................................................................................................................
..................................................................................................................
(7.8) 90 (21) 74 (13) 57 (6.5) 221 (12)
..................................................................................................................
(2.3) 29 (6.7) 18 (3.2) 4 (0.46) 51 (2.7)
..................................................................................................................
(0.00) 1 (0.23) 0 (0.00) 0 (0.00) 1 (0.05)
..................................................................................................................
(3.4) 31 (7.2) 31 (5.5) 31 (3.6) 93 (5.0)
..................................................................................................................
..................................................................................................................
(0.32) 3 (0.70) 1 (0.18) 4 (0.46) 8 (0.43)
..................................................................................................................
(0.37) 3 (0.70) 0 (0.00) 6 (0.69) 9 (0.48)
..................................................................................................................
(0.21) 0 (0.00) 0 (0.00) 2 (0.23) 2 (0.11)
..................................................................................................................
(0.19) 2 (0.47) 0 (0.00) 2 (0.23) 4 (0.21)
..................................................................................................................
(0.60) 0 (0.00) 3 (0.54) 5 (0.57) 8 (0.43)
..................................................................................................................
E, preeclampsia; PVL, periventricular leucomalacia; RDS,
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e newhe late preterm period, which is pre-
id fro Obst
www.AJOG.org Obstetrics Researchdominantly driven by gestational age
and mode of delivery. Very interestingly,
in our study the presence of a hyperten-
sive disorder per se seems to protect for
neonatal respiratory morbidity. How-
ever, this protective effect is diminished
by the higher cesarean rate in this group,
even resulting in higher incidences of re-
spiratory morbidity in case of a hyper-
tensive disorder. f
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